Nitric oxide and the immune response

Nature Immunology

Volumn 2, Issue 10, 2001, Pages 907-916

  Bogdan, C ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; DOXORUBICIN; FREUND ADJUVANT; INTERLEUKIN 12; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN; REACTIVE OXYGEN METABOLITE; THIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENCEPHALOMYELITIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INFECTION CONTROL; MOUSE; NONHUMAN; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTECTION; RAT; REVIEW; SIGNAL TRANSDUCTION; TOXICITY; TUMOR; UVEITIS; X RAY;

ANIMALS; AUTOIMMUNITY; BACTERIAL INFECTIONS; CHEMOTAXIS, LEUKOCYTE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTOZOAN INFECTIONS; RATS; THYMUS GLAND; VIRUS DISEASES;

EID: 0034769118     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1001-907     Document Type: Review

References (189)

1. Nitric oxide as a secretory product of mammalian cells
2. Nitric oxide and macrophage function
3. Mammalian nitric oxide synthases
4. Biochemistry of nitric oxide
5. The ectoenzyme γ-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes
6. Arginine metabolism: Nitric oxide and beyond
7. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
8. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species
9. Nitrosation and oxidation in the regulation of gene expression
10. Nitric oxide and the regulation of gene expression
11. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: A review
12. Inducible nitric oxide synthase in human diseases
13. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator
14. Antimicrobial properties of nitric oxide
15. Nitric oxide (NO): An effector of apoptosis
16. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
17. The function of nitric oxide in the immune system
18. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
19. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naïve and Leishmania major-infected mice
20. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells
21. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide
22. 2+/calmodulin-dependent isoform in human B and T lymphocytes
23. Calcium-dependent nitric oxide synthase activity in rat thymocytes
24. Nitric oxide synthase plays a signalling role in TCR-triggered apoptotic death
25. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric oxide synthase gene. Involvement of the RNA-binding protein HuR
26. Protein kinase Cd activation by interleukin-1β stabilizes inducible nitric oxide synthase mRNA in pancreatic β-cells
27. Identification of nitric oxide synthase as a protective locus against tuberculosis
28. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAKSTAT,AP-1 and NF-κB-signaling pathways
29. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression
30. Down-regulation of high mobility group-1(Y) protein contributes to the inhibition of nitric oxide synthase 2 by transforming growth factor-β1
31. Complex regulation of human iNOS gene transcription by Stat1 and NF-κB
32. Partial impairment of cytokine responses in tyk2-deficient mice
33. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophage cells: A role of Raf-1 in lipopolysaccharide signaling
34. Induction of inducible nitric oxide synthase-NO by lipoarabinomannan of Mycobacterium tuberculosis is mediated by the MEK1-ERK, MKK7-JNK and NF-κB signaling pathways
35. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric oxide synthase promotor activation
36. Co-stimulatory effect of nitric oxide on endothelial NF-κB implies a physiological self-amplifying mechanism
37. Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide
38. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOSI and NOSIII)
39. Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric oxide synthase
40. Caveolin-1 downregulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells
41. Inducible nitric oxide synthase is regulated by the proteasome degradation pathway
42. Solution structure of a protein inhibitor of neuronal nitric oxide synthase
43. An inducible nitric oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity
44. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
45. Direct interaction between endothelial nitric oxide synthase and dynamin-2
46. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric oxide synthase
47. Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric oxide synthase
48. Arginase modulates nitric oxide production in activated macrophages
49. Substrate supply for nitric oxide synthase in macrophages and endothelial cells: Role of cationic amino acid transporters
50. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2
51. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells
52. Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW264.7 cells
53. Stat6-dependent substrate depletion regulates nitric oxide production
54. IFN-γ and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation
55. Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro
56. Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle
57. Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line
58. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats
59. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase and lyase, with endothelial nitric oxide synthase
60. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects
61. Nitric oxide synthases: Which, where, how, and why?
62. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells
63. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection
64. Interferon-γ production by antigen presenting cells: Mechanisms emerge
65. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T cell leukemia virus type 1 and primary adult T-cell leukemia cells
66. Bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages
67. Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex
68. Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, SipD and effector SopE2
69. DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor-α and nitric oxide
70. Induction of direct antimicrobial activity through mammalian Toll-like receptors
71. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages
72. Nitric oxide and the control of firefly flashing
73. Regulation of gene expression by nitric oxide
74. A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: Implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion
75. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase
76. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
77. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants
78. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice
79. Nitric oxide inhibits neutrophil β2 integrin function by inhibiting membrane-associated cyclic cGMP synthesis
80. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia
81. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells
82. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression
83. Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro
84. Stromal cell-derived factor 1α-induced chemotaxis in T cells is mediated by itric oxide signaling pathways
85. Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated double-positive thymocytes
86. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens
87. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation
88. Nitric oxide induces apoptosis in mouse thymocytes
89. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxinitrite-driven apoptotic death
90. Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells
91. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase
92. + T cells in the antitumor immune response
93. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumor agents
94. The mosquito Anopheles stephensi limits malaria parasite development with inducible nitric oxide synthesis
95. Reversible binding of nitric oxide by a salivary heme protein from a bloodsucking insect
96. Sandfly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production
97. Tick salivary gland extract inhibits the killing of Borrelia afzelii spirochetes by mouse macrophages
98. NOS-2 mediates the protective anti-inflammatory and anti-fibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease
99. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
100. Differential regulation of nitric oxide synthase isoforms in experimental acute Chagasic cardiomyopathy
101. Induction of endothelial nitric oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment
102. Nitric oxide is neither necessary nor sufficient for resolution of Plasmodium chabaudi malaria in mice
103. Differential expression of nitric oxide synthases in bacterial meningitis: Role of the inducible isoform for blood-brain barrier breakdown
104. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro
105. Protein tyrosine nitration in cytokine-activated murine macrophages involvement of a peroxidase/nitrite pathway rather than peroxinitrite
106. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates
107. Peroxynitrite reductase activity of bacterial peroxiredoxins
108. Role of arginase in killing of schistosomula of Schistosoma mansoni
109. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia
110. L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: Contribution of the nitric oxide and polyamine pathways
111. ω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages
112. L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis
113. Requirement for type 2 NO-synthase for IL-12 responsiveness in innate immunity
114. Effect of nitric oxide donors on oxygen-dependent cytotoxic responses by neutrophils
115. Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxinitrite
116. Interferon-γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
117. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice
118. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
119. Role of nitric oxide in wound healing
120. Macrophage microbicidal mechanisms in vivo: Reactive nitrogen vs. oxygen intermediates in the killing of intracellular visceral Leishmania donovani
121. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects of microbial proliferation and host survival in vivo
122. Expression of nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung
123. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection
124. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking tumor necrosis factor
125. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of IFN-γ and nitric oxide synthase 2
126. T cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis
127. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
128. Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-β (TGF-β) in leprosy lesions
129. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria
130. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria
131. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria
132. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria
133. Role of inducible nitric oxide synthase in transplant atherosclerosis
134. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection
135. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction
136. The multiplex function of nitric oxide in (auto)immunity
137. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2
138. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease
139. Interleukin-12 protects from a Th1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving IFN-γ, nitric oxide and apoptosis
140. Adjuvant immunotherapy is dependent on inducible nitric oxide synthase
141. Control of the autoimmune response by type 2 nitric oxide synthase
142. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration
143. Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase
144. Activation of nitric oxide gene for inhibition of cancer metastasis
145. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of cyclin D1
146. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis
147. + cells in the spleen of cyclophosphamide-treated mice: Implications for T cell responses in immunosuppressed mice
148. Zinc finger transcription factor as molecular target for nitric oxide-mediated immunosuppression: Inhibition of IL-2 gene expression in lymphocytes
149. A Sp1 binding site of the tumor necrosis factor α promotor functions as a nitric oxide response element
150. Regulation of transforming growth factor β1 by nitric oxide
151. Activation of tumor necrosis factor-α-converting enzyme-mediated ectodomain shedding by nitric oxide
152. The heme-regulated eukaryotic initiation factor 2α kinase. A potential regulatory target for control of protein synthesis by diffusible gases
153. NO as a signaling molecule: Effects on kinases
154. Effects of nitric oxide on the induction and differentiation of Th1 cells
155. Constitutive nitric oxide production by rat alveolar macrophages
156. Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: Stimulation by soluble CD23
157. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase
158. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide
159. Involvement of NO in contact hypersensitivity
160. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells. Nitric oxide production is associated with dendritic cell apoptosis
161. Fate of Mycobacterium tuberculosis within murine dendritic cells
162. LPS induction of 1κB-α degradation and iNOS expression in a skin dendritic cell line is prevented by the Janus kinase 2 inhibitor, tyrphostin B42
163. Nitric oxide synthase-2 and expression of perforin in uterine NK cells
164. Interleukin-2 activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-γ production
165. The induction of nitric oxide by interleukin-12 and tumor necrosis factor-α in human natural killer cells: Relationship with the regulation of lytic activity
166. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-α
167. Fas-induced caspase denitrosylation
168. Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes
169. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
170. Inducible nitric oxide synthase plays a minimal role in LCMV-induced, T cell-mediated protective immunity and immunopathology
171. Role of nitric oxide synthase type 2 in acute infection with cytomegalovirus
172. Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase
173. Development of Lyme arthritis in mice deficient in inducible nitric oxide synthase
174. Inducible nitric oxide synthase: What difference does it make?
175. Role of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice
176. Genetic dissection of primary and secondary responses to a widespread natural pathogen of the gut, Eimeria vermiformis
177. IFN-γ-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis
178. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection
179. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice
180. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice
181. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase
182. Neural route of cerebral Listeria monocytogenes murine infection: Role of immune response mechanisms in controlling bacterial neuroinvasion
183. Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model
184. Innate immunity to amebic liver abscess is dependent on γ interferon and nitric oxide in a murine model of disease
185. T cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase
186. Expression of cardiac cytokines and inducible nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice
187. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme
188. Viral mutation accelerated by nitric oxide production during infection in vivo
189. Nitric oxide synthase protection against Coxsackievirus pancreatitis